Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIVER: Kick and Kill Strategy for HIV Eradication
NCT02336074Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Nov 2015
- Primary completion
- Nov 2017
- Modality
- Prophylactic Vaccines, DNA Vaccines, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ChAdV63.HIVconsv, MVA.HIVconsv, vorinostat in human immunodeficiency virus infection (HIV), sponsored by Imperial College London. Started Nov 2015; status: completed.
02
Drugs
ChAdV63.HIVconsvMVA.HIVconsvvorinostat
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02336074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336074.